Second Nature logo

US

GLP-1s

Can you take Mounjaro with depression?

Robbie Puddick
Written by

Robbie Puddick

Medically reviewed by

Fiona Moncrieff

4 min read
Last updated December 2024
Share
FacebookTwitter
title

Jump to: Understanding the link between depression and obesity | How does Mounjaro affect mental health? | Taking Mounjaro with antidepressants | Take home message

You can take Mounjaro (tirzepatide) if you have depression, and emerging research suggests it may offer beneficial effects on mental health beyond its primary role in weight management.

Clinical trials demonstrate that people taking Mounjaro experienced significant improvements in mental health and psychosocial function compared to those taking a placebo.

Research has shown that people living with diabetes taking tirzepatide had a 65% lower likelihood of being diagnosed with depression compared to those not taking the medication.

While these findings are promising, it’s essential to understand that Mounjaro isn’t a treatment for depression, and any existing mental health treatment should continue under medical supervision.

Medication-assisted weight loss with a future focus

Start with Wegovy or Mounjaro, transition to habit-based health with our support

Mounjaro pen
Wegovy pen

Understanding the link between depression and obesity

The relationship between depression and obesity is complex and bidirectional, with each condition influencing the development of the other.

Research suggests that obesity increases the risk of developing depression by approximately 55%, while depression increases the risk of developing obesity by about 58%.

This creates a challenging cycle that can be difficult to break without a deeper understanding of how to treat both conditions.

Depression affects 23% of people living with obesity compared to 11% of people with a lower BMI, with women being more likely to experience both conditions simultaneously.

This higher prevalence isn’t simply about weight – it reflects a complex interplay of biological, psychological, and social factors.

The connection between these conditions involves multiple mechanisms.

Chronic inflammation can affect brain function and mood regulation, while hormonal imbalances can influence both weight and emotional well-being.

Changes in brain signalling and the gut-brain axis further complicate this relationship.

Beyond biological factors, behavioural changes often play a crucial role. Depression can lead to decreased physical activity, altered eating patterns, and disrupted sleep – all of which can impact weight management.

Similarly, living with obesity can affect self-esteem, social interactions, and overall quality of life, potentially contributing to depressive symptoms.

How does Mounjaro affect mental health?

The SURMOUNT-1 trial, which included over 2,500 participants, provided valuable insights into Mounjaro’s effects on mental health and quality of life.

Researchers found significant improvements across several mental health outcomes using validated assessment tools, including the Short Form 36 health survey (SF-36v2) and the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT).

Participants taking Mounjaro showed enhanced emotional functioning, better social interactions, and improved overall mental well-being compared to those taking a placebo.

All doses of Mounjaro (5mg, 10mg, and 15mg) demonstrated statistically significant improvements, with higher doses generally showing greater benefits.

Mechanisms and biological factors

Scientists believe Mounjaro influences mental health through several pathways in the body.

One key mechanism involves its anti-inflammatory effects. Chronic inflammation affects brain function and mood regulation, and by reducing systemic inflammation, Mounjaro may help improve overall brain health and emotional well-being.

The medication’s impact on metabolic health also plays a crucial role. By enhancing blood sugar control and reducing insulin resistance, Mounjaro helps stabilise energy levels throughout the day.

This improvement in energy levels can have profound effects on mood, as blood sugar fluctuations often influence emotional stability and cognitive function.

Mounjaro’s influence on gut hormone signalling represents another potential pathway for improving mental health.

The gut-brain connection is increasingly recognised as vital for emotional well-being, and by optimising this communication system, Mounjaro may help regulate mood and appetite.

The significant weight loss achieved with Mounjaro – an average of 26% after one year – can also contribute to improved mental health through various mechanisms.

Beyond the physical benefits, weight loss often leads to enhanced mobility, better self-image, and reduced exposure to weight stigma, all of which can positively impact psychological well-being.

Taking Mounjaro with antidepressants

There are currently no known interactions between Mounjaro and common antidepressant medications. This includes SSRIs (like sertraline and fluoxetine), SNRIs (such as venlafaxine), and other types of antidepressants.

However, as Mounjaro is a relatively new medication, ongoing monitoring and communication with your healthcare team remain essential.

Your doctor might adjust your treatment plan based on your individual response to the medications.

Some patients find that as their physical health improves with Mounjaro, their mental health management needs may change.

Managing depression while taking Mounjaro requires a balanced approach that addresses both physical and mental health.

This might include regular physical activity, which can help manage weight while producing mood-boosting endorphins. Adequate sleep proves crucial, as poor sleep can affect mood and weight.

A diet rich in whole foods, with adequate protein and essential nutrients, can support mental health and weight management goals.

Some patients find that as Mounjaro helps reduce hunger and food-related thoughts, they can focus more energy on developing sustainable healthy habits.

Psychological support remains vital. This might include cognitive behavioural therapy, which can help address thought patterns affecting mood and eating behaviours.

Support groups or counselling can provide additional tools for managing the emotional aspects of both conditions.

Take home message

The relationship between depression and obesity is complex, but emerging research suggests Mounjaro may offer benefits beyond weight loss by potentially improving mental health outcomes.

While you can safely take Mounjaro alongside antidepressants, success depends on a comprehensive approach that addresses both physical and mental wellbeing.

Second Nature’s medication programmes

Second Nature has two medication-supported programmes: a Wegovy weight-loss programme and a Mounjaro weight-loss programme.

Why should you choose Second Nature over other medication providers if you’ve decided to try Mounjaro or Wegovy (assuming you’re eligible)?

For peace of mind.

Second Nature has worked with the NHS for over 6 years, providing weight-loss programmes across the UK.

While our Wegovy and Mounjaro weight-loss programmes are private and not currently used by the NHS, we’ve built the programmes focusing on scientific evidence, patient safety, and data security.

We hope that our 6+ years of working with the NHS and building a track record of effective weight-loss results will give you peace of mind to give us a try.

Medication-assisted weight loss with a future focus

Start with Wegovy or Mounjaro, transition to habit-based health with our support

Mounjaro pen
Wegovy pen
Meal Plan

Maximise your weight loss on Wegovy/Mounjaro with our free 7-day meal plan

Get expert advice from our team of registered dietitians to make losing weight feel easier while on medication. Subscribe to our newsletter to get access today.

I've read and agreed to the Terms of Service & Privacy Policy.

You might also like

Make losing weight feel Second Nature

The first step on your Second Nature journey is to take our health quiz.

Hand holding phone

Write a response

As seen on

The GuardianThe TimesChannel 4The Sunday Telegraph
Evening Standard
Metro